I-FDA ivumile umuthi omusha we-smallpox

Namuhla, i-US FDA imemezele ukuvunyelwa komuthi omusha we-SIGA Technologies i-TPOXX (tecovirimat) wokwelapha ingxibongo. Kuhle ukusho ukuthi lo umuthi omusha wama-21 ovunyelwe yi-US FDA kulo nyaka kanye nomuthi omusha wokuqala ovunyelwe ukwelapha ingxibongo.

Igama le-smallpox, abafundi bemboni yezokwelapha ngeke bajwayele. Umuthi wokugomela i-smallpox uwumuthi wokuqala wokugomela owenziwe ngempumelelo ngabantu, futhi sinesikhali sokuvimbela lesi sifo esibulalayo. Selokhu kwagonyelwa imijovo ye-smallpox, abantu bawine ukunqoba empini yokulwa namagciwane. Ngo-1980, i-World Health Organization yamemezela ukuthi sesiqede usongo lwe-smallpox. Lolu hlobo lwesifo esithathelwanayo, oluye lwathinteka kakhulu futhi okukhulunywa ngalo, luye lwanyamalala kancane kancane emehlweni abantu.

Kodwa ngenxa yobunzima besimo samazwe ngamazwe kula mashumi eminyaka, abantu baqala ukukhathazeka ngokuthi igciwane le-smallpox lingase lenziwe izikhali zezinto eziphilayo, okusongela izimpilo zabantu abavamile. Ngakho-ke, abantu banquma nokuthuthukisa umuthi ongelapha i-smallpox uma kwenzeka isimo esiphuthumayo. I-TPOXX yaba khona. Njengomuthi wokulwa namagciwane, ingahlasela ngempumelelo ukusabalala kwegciwane le-variola emzimbeni. Ngokusekelwe emandleni ayo, lo muthi omusha unikezwe iziqu ezisheshayo, iziqu zokubuyekezwa okubalulekile, kanye neziqu zemithi yezintandane.

Ukusebenza kahle nokuphepha kwalesi sidakamizwa esisha kuye kwahlolwa ezivivinyweni zezilwane kanye nabantu, ngokulandelana. Ezivivinyweni zezilwane, izilwane ezinegciwane le-TPOXX zaphila isikhathi eside kunalezo ezelashwe nge-placebo ngemva kokutheleleka ngegciwane le-variola. Ezivivinyweni zabantu, abacwaningi baqashe abantu abangu-359 abanempilo (abangenalo ukutheleleka nge-smallpox) futhi babacela ukuthi basebenzise i-TPOXX. Izifundo zikhombisile ukuthi imiphumela emibi evame kakhulu ikhanda elibuhlungu, isicanucanu, kanye nobuhlungu besisu ngaphandle kwemiphumela emibi emibi kakhulu. Ngokusekelwe ekusebenzeni kahle okuboniswe ezivivinyweni zezilwane kanye nokuphepha okuboniswe ezivivinyweni zabantu, i-FDA ivumile ukwethulwa kwalesi sidakamizwa esisha.

"Ngenxa yengozi yobuphekula bezinto eziphilayo, iCongress ithathe izinyathelo zokuqinisekisa ukuthi amagciwane asetshenziswa njengezikhali, futhi sithuthukise futhi savuma izindlela zokulwa nalesi sifo. Ukuvunyelwa kwanamuhla kumelela ingqophamlando enkulu kule mizamo!" UMqondisi we-FDA uScott Gottlieb Udokotela uthe: "Lona umuthi omusha wokuqala ukunikezwa isibuyekezo sokuqala 'se-Material Threat Medical Countermeasure'. Ukuvunyelwa kwanamuhla kubonisa nokuzibophezela kwe-FDA ekuqinisekiseni ukuthi sikulungele inkinga yezempilo yomphakathi futhi sinikeze ukuphepha ngesikhathi. Imikhiqizo emisha yemithi esebenzayo."

Nakuba lo muthi omusha kulindeleke ukuthi welaphe ingxibongo, sisalindele ukuthi ingxibongo ngeke ibuye, futhi sibheke phambili osukwini lapho abantu bengeke baphinde bawusebenzise lo muthi omusha.